Ovid Therapeutics Inc. ( OVID) - Key Metrics

OVID Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0 -$0.08 -$0.09 -$0.09
2026Q1 $0 -$0.23 -$0.19 -$0.19
2025Q4 $0.01 $0.12 -$0.13 -$0.13
2025Q3 $0 -$0.17 -$0.18 -$0.18
2025Q2 $0.09 -$0.07 -$0.07 -$0.07

OVID Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% -8.41
2026Q1 0% -2.41
2025Q4 0% 3.40
2025Q3 0% -1.91
2025Q2 0% -1.25

OVID

Price: $2.89

52 week price:
0.48
3.11

Earnings Per Share: -0.21 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 61100

Ebitda: -9.4 million

Market Capitalization: 522.6 million

Links: